Encompass Health Corporat... (EHC)
NYSE: EHC
· Real-Time Price · USD
126.79
2.19 (1.76%)
At close: Sep 11, 2025, 3:59 PM
125.41
-1.09%
After-hours: Sep 11, 2025, 06:20 PM EDT
Encompass Health Revenue Breakdown
| Period Ending | Jun 30, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|
| Managed Care Revenue | 163M | 148.1M | 138.7M | 142.8M | 135.4M | 133.5M | 127.1M | 126.1M |
| Managed Care Revenue Growth | +10.06% | +6.78% | -2.87% | +5.47% | +1.42% | +5.04% | +0.79% | n/a |
| Medicaid Revenue | 45.2M | 46.1M | 43M | 44.8M | 49.2M | 48.8M | 47.4M | 47.7M |
| Medicaid Revenue Growth | -1.95% | +7.21% | -4.02% | -8.94% | +0.82% | +2.95% | -0.63% | n/a |
| Medicare Revenue | 939.7M | 883.3M | 841.6M | 854.1M | 786.5M | 763.2M | 757.7M | 711.2M |
| Medicare Revenue Growth | +6.39% | +4.95% | -1.46% | +8.60% | +3.05% | +0.73% | +6.54% | n/a |
| Patients Revenue | 4.6M | 4.1M | 3.7M | 3.9M | 3.8M | 4M | 2.7M | 3.5M |
| Patients Revenue Growth | +12.20% | +10.81% | -5.13% | +2.63% | -5.00% | +48.15% | -22.86% | n/a |
| Workers' Compensation Revenue | 7.5M | 7M | 6.8M | 7M | 6.6M | 7.3M | 5.7M | 6.9M |
| Workers' Compensation Revenue Growth | +7.14% | +2.94% | -2.86% | +6.06% | -9.59% | +28.07% | -17.39% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 59.4M | 67.2M | 69.2M | 54M | 50.5M | 50.2M | 53.1M | 722.6M | 705.9M | 686.2M | 670.3M | 655.9M | 853.4M | 845.3M | 841.6M | 793.8M | 782.6M | 746M | 744.3M | 724.3M | 715.2M | 734.9M | 753.1M | 735.1M | 720.3M | 693.8M | 687.9M | 661.8M | 652.6M | 649.9M | 616.4M | 600.4M | 598.5M | 584.5M | 570.9M | 545.3M | 540.1M | 536.2M | 519.9M | 460.6M | 446.5M | 434M |
| Selling, General, and Administrative Revenue Growth | -11.61% | -2.89% | +28.15% | +6.93% | +0.60% | -5.46% | -92.65% | +2.37% | +2.87% | +2.37% | +2.20% | -23.14% | +0.96% | +0.44% | +6.02% | +1.43% | +4.91% | +0.23% | +2.76% | +1.27% | -2.68% | -2.42% | +2.45% | +2.05% | +3.82% | +0.86% | +3.94% | +1.41% | +0.42% | +5.43% | +2.66% | +0.32% | +2.40% | +2.38% | +4.69% | +0.96% | +0.73% | +3.14% | +12.87% | +3.16% | +2.88% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |